FTC Merger Guidelines Cast ‘Perilous Shadow’ Over Biopharma

 
• By Brenda Sandburg
Merger shadow
BIO and others recommend changes to FTC-DOJ proposed revision to merger guidelines. • Source: Shutterstock

More from Compliance

More from Pink Sheet